Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity

被引:46
作者
Tache, Veronique [2 ,5 ]
LaCoursiere, D. Yvette [2 ]
Saleemuddin, Aasia [3 ]
Parast, Mana M. [1 ,4 ]
机构
[1] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA
[3] Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02108 USA
[4] Brigham & Womens Hosp, Dept Pathol, Div Womens & Perinatal Pathol, Boston, MA 02108 USA
[5] Univ Calif Davis, Dept Reprod Med, Sacramento, CA 95817 USA
关键词
Preeclampsia; Syncytial knots; Placental hypermaturity; sFlt-1; ANGIOGENIC FACTORS; TYROSINE KINASE-1; GESTATIONAL HYPERTENSION; PREGNANCY; RISK; SINGLETON; HYPOXIA; SFLT-1; OXYGEN;
D O I
10.1016/j.humpath.2010.11.018
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Overexpression of soluble vascular endothelial growth factor receptor-1 has been linked to preeclampsia and is thought to be secondary to placental insufficiency caused by hypoxia. Villous hypermaturity, characterized by presence of increased syncytial knots, has been associated with syndromes of placental insufficiency, particularly when severe. This study was undertaken to determine whether there is a link between soluble vascular endothelial growth factor receptor-1 expression, villous hypermaturity, and clinical severity of preeclampsia. We conducted a retrospective cohort study in which 48 placentas were selected from pathology archives (hypertensive group). Of these, 6 had chronic hypertension, 15 had mild preeclampsia, 14 had severe preeclampsia, and 13 had hemolysis, elevated liver enzymes, and low platelets syndrome. These were compared with 55 placentas from normotensive patients (control group). One representative section of placental parenchyma from each case was stained with an antibody to vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 and given a score based on extent and intensity of staining, representing expression level. Assignment of staining score was done, blinded to clinical history and pathologic diagnosis. Vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 staining was seen in placental syncytiotrophoblasts and was particularly strong in syncytial knots. There was a positive association between vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 staining score and severity of clinical hypertensive state, small placental size, and villous hypermaturity. The association between vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 score and small placentas did not persist after controlling for hypermaturity. Vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 overexpression in the placenta strongly correlates with both severity of hypertensive disease and villous hypermaturity. The correlation with villous hypermaturity further links hypoxia to vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 production in the placenta. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:1283 / 1288
页数:6
相关论文
共 23 条
[1]  
[Anonymous], 2000, AM J OBSTET GYNECOL, V183, pS1
[2]   Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia [J].
Buchbinder, A ;
Sibai, BM ;
Caritis, S ;
MacPherson, C ;
Hauth, J ;
Lindheimer, MD ;
Klebanoff, M ;
VanDorsten, P ;
Landon, M ;
Paul, R ;
Miodovnik, M ;
Meis, P ;
Thurnau, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (01) :66-71
[3]   Maternal ethnicity, paternal ethnicity, and parental ethnic discordance - Predictors of preeclampsia [J].
Caughey, AB ;
Stotland, NE ;
Washington, AE ;
Escobar, GJ .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) :156-161
[4]   A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation [J].
Clark, DE ;
Smith, SK ;
He, YL ;
Day, KA ;
Licence, DR ;
Corps, AN ;
Lammoglia, R ;
Charnock-Jones, DS .
BIOLOGY OF REPRODUCTION, 1998, 59 (06) :1540-1548
[5]   Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies [J].
Duckitt, K ;
Harrington, D .
BRITISH MEDICAL JOURNAL, 2005, 330 (7491) :565-567
[6]   Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia [J].
Jeyabalan, Arun ;
Powers, Robert W. ;
Durica, Allison R. ;
Harger, Gail F. ;
Roberts, James M. ;
Ness, Roberta B. .
AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (08) :943-947
[7]   Hypoxia and sFlt-1 in preeclampsia: The "chicken-and-egg" question [J].
Karumanchi, SA ;
Bdolah, Y .
ENDOCRINOLOGY, 2004, 145 (11) :4835-4837
[8]  
Kraus FT., 2004, ATLAS NONTUMOR PATHO
[9]   Circulating angiogenic factors and the risk of preeclampsia [J].
Levine, RJ ;
Maynard, SE ;
Qian, C ;
Lim, KH ;
England, LJ ;
Yu, KF ;
Schisterman, EF ;
Thadhani, R ;
Sachs, BP ;
Epstein, FH ;
Sibai, BM ;
Sukhatme, VP ;
Karumanchi, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :672-683
[10]  
LOUKERIS K, 2009, PEDIAT DEV PATHOL